Events & Conferences

In this section, explore the key scientific events and conferences where Clinisciences takes center stage—whether as a sponsor or an active participant. From high-impact international congresses to focused expert symposia, our presence reflects our dedication to advancing research and connecting with the scientific community. These events are more than just dates on a calendar—they're opportunities to exchange ideas, showcase innovative tools, and stay at the forefront of scientific discovery. Join us where breakthroughs happen!

CNR Institute of Neuroscience Annual Congress 2026

CliniSciences wird auf dem Jahreskongress 2026 des CNR-Instituts für Neurowissenschaften vertreten sein, der vom 14. bis 16. Oktober in Padua, Italien, stattfindet. Entdecken Sie die wichtigsten wissenschaftlichen Themen dieser Veranstaltung und treffen Sie unser Team, um über Forschung in den Bereichen Neurowissenschaften, Biomedizin sowie Zell- und Molekularbiologie zu diskutieren.

IFN-λ Satellite Workshop 2026

CliniSciences is proud to attend the IFN-λ Satellite Workshop 2026, taking place on 22 October 2026 in Glasgow, Scotland. This scientific event will bring together leading experts and researchers to explore advances in interferon lambda (IFN-λ) biology, cytokine signaling, immune regulation, and antiviral immunity, fostering scientific exchange and collaboration in immunology research.

XXIV Congresso Nazionale AIBG

CliniSciences is proud to attend the XXIV AIBG National Congress, taking place from 22 to 24 October 2026 in Camogli, Italy. This scientific event will bring together the research community to explore advances in cell biology, molecular genetics, genomics, and epigenetics, fostering scientific exchange and collaboration.

European Synapse Meeting 2026

CliniSciences wird am European Synapse Meeting 2026 teilnehmen, das vom 21. bis 23. Oktober 2026 in Leuven, Belgien, stattfindet. Bei dieser 10. Ausgabe der Tagung wird die internationale wissenschaftliche Gemeinschaft zusammenkommen, um die neuesten Fortschritte in den Bereichen Synapsenbiologie, neuronale Konnektivität, Neurowissenschaften und Mechanismen der neurologischen Entwicklung zu diskutieren. Entdecken Sie die wichtigsten wissenschaftlichen Themen des Kongresses und treffen Sie CliniSciences auf dieser führenden Veranstaltung zur Synapsenforschung.

Annual meeting of the FNRS Contact Group "Metabolism"

The 3rd Annual Meeting of the FNRS Contact Group “Metabolism”, taking place on 29 October 2026 in Namur, Belgium, will bring together researchers and experts to explore the regulation of metabolic pathways, their role in biological processes, and the contribution of metabolic dysfunction to disease. This event will foster scientific exchange, knowledge sharing, and discussions on recent advances in metabolism research.

Evita Workshop 2026 on EV-based Therapeutics

The EVIta Workshop 2026, taking place on 28–29 October in Como, Italy, will bring together researchers and experts to explore the latest scientific advances in extracellular vesicles, their engineering, and therapeutic applications. This event will provide a valuable opportunity for knowledge sharing, scientific exchange, and collaboration in this rapidly evolving field of research.

Annual Oxford Stem Cell Institute Symposium

The Oxford Stem Cell Institute Symposium, taking place on 2–3 November in Oxford, United Kingdom, will bring together researchers and clinicians to explore the latest advances in stem cell biology and regenerative medicine. Held under the theme “Stem Cells: From Mechanism to Therapy,” the symposium will highlight key research areas, including cellular plasticity, cancer stem cells, organoids, tissue engineering, and emerging therapeutic approaches.

Microbiology Society Annual Meeting in Ireland

The Microbiology Society Annual Meeting in Ireland 2026, taking place on 3–4 November in Athlone, Ireland, will bring together researchers and microbiology specialists to share the latest advances in microbiology research. The programme will feature scientific presentations, poster sessions, interdisciplinary discussions, and a dedicated session on developing affordable vaccines. This event will also provide valuable opportunities for early-career researchers and PhD students to present their work, exchange knowledge, and expand their professional networks.

NEVBO Annual 2026 Meeting

CliniSciences wird an der NEVBO-Jahrestagung 2026 vom 5. bis 6. November in Groningen teilnehmen, einer wissenschaftlichen Veranstaltung, die sich mit Gefäßbiologie, Endothelforschung und Mikrozirkulation befasst.

36th GISN National Congress

Join CliniSciences at the 36th GISN National Congress in Rome on 27–28 November 2026, bringing together the neuroscience research community to discuss neuromorphology, neurodegeneration, neuroinflammation and emerging research approaches.

21st ASEICA International Congress

Join CliniSciences at the 21st ASEICA International Congress in Seville, Spain, from 25–27 November 2026, to connect with the cancer research community and explore the latest developments in cancer biology, innovative therapeutic strategies, and biomedical research.

CliniSciences & ACOBIOM Secure European Funding for PANTHERA Dx

CliniSciences und ACOBIOM starten das Projekt PANTHER-VALID, das im Rahmen des EP PerMed Fast Track ausgewählt wurde, um PANTHERA Dx zu validieren – einen KI-gestützten Bluttest auf der Grundlage von RNA-Biomarkern, der als Orientierungshilfe bei der Wahl der Erstlinienbehandlung beim duktalen Adenokarzinom des Pankreas dienen soll.

Press Release: Genexpath joins CliniSciences Group

CliniSciences strengthens its leadership in molecular biology and hemato-oncology with the strategic acquisition of Genexpath, a specialist in in vitro diagnostic solutions for lymphomas and sarcomas.

REDINN besucht NEOSETAC-Unternehmenspartner in Barcelona

REDINN besucht NEOSETAC-Unternehmenspartner in Barcelona

Pressemitteilung : Oncomedics tritt der CliniSciences-Gruppe bei

Die CliniSciences Group, ein europäischer Vertreiber von Reagenzien und Geräten für die wissenschaftliche Forschung und medizinische Diagnostik, hat Oncomedics übernommen, ein französisches Biotechnologieunternehmen, das sich auf die Personalisierung von Krebsbehandlungen spezialisiert hat.